# Sub-Q Bionics Closes $1.5M Pre-Seed Round Backed by Mayo Clinic and Weizmann Institute

> financing · REPORTED · 2026-03-31

Sub-Q Bionics closed a $1.5 million pre-seed funding round with investment from Mayo Clinic and Yeda, the technology transfer arm of the Weizmann Institute of Science, plus matching funds from the Israel Innovation Authority. Proceeds will advance development of the company's bionic lymph node implant technology for lymphedema management.

About Subqbionics: Sub-Q Bionics is a Stillwater, Minnesota and Tel Aviv medical device company developing an implantable subcutaneous bionic lymph node system designed to provide automatic lymphatic fluid management for patients living with lymphedema, a chronic condition common among cancer survivors.

- Company: Subqbionics
- Sector: medical devices
- Primary source: https://www.businesswire.com/news/home/20260330377271/en/Sub-Q-Bionics-Closes-%241.5M-Pre-Seed-Round-to-Advance-Next-Generation-Solution-for-Lymphedema-Care

---
Source: MedFuel Intel news monitor. Verification tier: REPORTED. Informational only, not investment advice. Corrections: media@medfuelinc.com.